Gilead fails FDA approval for two HIV drugs in 4-in-1 pill Stribild

Gilead Sciences failed to win U.S. regulatory approval to sell as separate products two HIV medicines that are part of its four-in-one pill Stribild.

http://www.mercurynews.com/business/ci_23130395/gilead-fails-fda-approval-two-hiv-drugs-4?source=rss